---
title: "SINOPHARM's subsidiary SINOPHARM(CNCM LTD) earned 1.997 billion RMB for the year, a slight decrease of 0.2%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279821917.md"
description: "SINOPHARM announced that its subsidiary SINOPHARM(CNCM LTD) achieved an operating revenue of 52.468 billion RMB for the fiscal year 2025, an increase of 3.7% year-on-year. The net profit attributable to shareholders was 1.997 billion RMB, a slight decrease of 0.2%, with earnings per share of 2.6462 RMB"
datetime: "2026-03-19T16:04:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279821917.md)
  - [en](https://longbridge.com/en/news/279821917.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279821917.md)
---

# SINOPHARM's subsidiary SINOPHARM(CNCM LTD) earned 1.997 billion RMB for the year, a slight decrease of 0.2%

SINOPHARM (01099.HK) announced that its subsidiary SINOPHARM(CNCM LTD) (600511.SH) achieved an operating revenue of RMB 52.468 billion for the fiscal year 2025, an increase of 3.7% year-on-year. The net profit attributable to shareholders was RMB 1.997 billion, a slight decrease of 0.2%, with earnings per share of RMB 2.6462

### Related Stocks

- [000028.CN](https://longbridge.com/en/quote/000028.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [01099.HK](https://longbridge.com/en/quote/01099.HK.md)
- [600511.CN](https://longbridge.com/en/quote/600511.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)

## Related News & Research

- [Sinopharm subsidiary posts steady Q1 profit growth but cash flow weakens](https://longbridge.com/en/news/283669573.md)
- [CICC Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)](https://longbridge.com/en/news/284328826.md)
- [Sinopharm Group Co (SHTDF) Receives a Buy from Citi](https://longbridge.com/en/news/293537091.md)
- [HBM Holdings enters strategic biologics R&D collaboration with Sinopharm](https://longbridge.com/en/news/293905042.md)
- [Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape](https://longbridge.com/en/news/285930281.md)